The landscape of viral associations in human cancers

Keyphrases

• Virus 100%
• Viral 100%
• Hepatitis B Virus 100%
• HPV16 100%
• HPV18 100%
• Human Cancer 100%
• Whole Genome 100%
• Tumor 50%
• Tumor Subtype 50%
• Consensus Approach 50%
• High-risk Human Papillomavirus (HR-HPV) 50%
• Bladder 50%
• Head-and-neck Cancer 50%
• High Prevalence 50%
• Antiviral Response 50%
• Viral Integration 50%
• Sequence Data 50%
• Epstein-Barr Virus 50%
• Adeno-associated Virus Type 2 50%
• Virus Hepatitis 50%
• Genome Copy number 50%
• Transcriptome Sequencing 50%
• Survival Outcomes 50%
• Head-and-neck Squamous Cell Carcinoma (HNSCC) 50%
• Tumor-associated 50%
• Transcriptomic Data 50%
• Kidney Cancer 50%
• Viral Pathogens 50%
• Driver mutations 50%
• Pan-cancer Analysis 50%
• Endogenous Retrovirus 50%
• TERT Promoter 50%
• Local Variation 50%
• Telomerase Expression 50%
• Exclusivity 50%
• APOBEC mutational Signature 50%
• Driving Process 50%

Immunology and Microbiology

• Hepatitis B Virus 100%
• Human Papillomavirus Type 16 100%
• Neck 100%
• Human Papillomavirus Type 18 100%
• Virus 100%
• Prevalence 50%
• Wart Virus 50%
• Infectious Agent 50%
• Promoter Region 50%
• Hepatitis Virus 50%
• Transcriptome 50%
• RNA Sequencing 50%
• Adeno Associated Virus 2 50%
• Endogenous Retrovirus 50%

Biochemistry, Genetics and Molecular Biology

• Human Papillomavirus Type 16 100%
• Human Papillomavirus Type 18 100%
• Hepatitis B Virus 100%
• Promoter Region 50%
• Infectious Agent 50%
• Prevalence 50%
• APOBEC 50%
• Adeno Associated Virus 2 50%
• RNA Sequencing 50%
• Telomerase 50%
• Endogenous Retrovirus 50%
• Hepatitis Virus 50%
• Genomics 50%
• Wart Virus 50%
• Transcriptome 50%
• Pan-cancer 50%